DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $23.00 by Analysts at Morgan Stanley

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price lowered by Morgan Stanley from $30.00 to $23.00 in a research report sent to investors on Tuesday morning,Benzinga reports. Morgan Stanley currently has an overweight rating on the medical instruments supplier’s stock.

A number of other analysts have also issued reports on XRAY. Leerink Partners lowered DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Mizuho began coverage on shares of DENTSPLY SIRONA in a report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 target price for the company. Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, Robert W. Baird lowered their price objective on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research note on Friday, November 8th. Eight investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $27.91.

DENTSPLY SIRONA Stock Performance

XRAY opened at $18.47 on Tuesday. The firm’s fifty day simple moving average is $20.96 and its two-hundred day simple moving average is $24.01. DENTSPLY SIRONA has a 52-week low of $17.21 and a 52-week high of $37.60. The company has a market cap of $3.67 billion, a price-to-earnings ratio of -8.92, a PEG ratio of 1.93 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. During the same period last year, the company posted $0.49 EPS. DENTSPLY SIRONA’s quarterly revenue was up .4% compared to the same quarter last year. Equities analysts anticipate that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be issued a $0.16 dividend. The ex-dividend date is Friday, December 27th. This represents a $0.64 annualized dividend and a yield of 3.47%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -30.92%.

Institutional Investors Weigh In On DENTSPLY SIRONA

Institutional investors and hedge funds have recently modified their holdings of the company. UMB Bank n.a. grew its stake in shares of DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after acquiring an additional 753 shares in the last quarter. Capital Performance Advisors LLP purchased a new stake in shares of DENTSPLY SIRONA in the 3rd quarter valued at approximately $27,000. LRI Investments LLC raised its holdings in shares of DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after purchasing an additional 564 shares in the last quarter. Kennebec Savings Bank purchased a new stake in shares of DENTSPLY SIRONA during the 3rd quarter worth $35,000. Finally, Rothschild Investment LLC acquired a new position in shares of DENTSPLY SIRONA during the second quarter worth $32,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.